According to FutureWise analysis the market for antiplatelet drugs in 2023 is US$ 2.41 billion, and is expected to reach US$ 4.56 billion by 2031 at a CAGR of 8.30%.
Antiplatelet medications are categorized into oral and parenteral agents, with further subdivisions based on their mechanisms of action. Oral antiplatelet drugs encompass aspirin, a cyclooxygenase inhibitor, clopidogrel, ticagrelor, prasugrel, Cilostazol, and dipyridamole. Parenteral glycoprotein IIb/IIIa inhibitors like tirofiban and eptifibatide are exclusively used in acute phases of acute coronary syndrome.
These medications serve a multitude of clinical indications, including acute coronary syndrome, post-percutaneous coronary intervention with stenting, and acute ischemic stroke, among others. Mechanistically, antiplatelets operate through various pathways. Aspirin, the most widely used oral antiplatelet, irreversibly inhibits cyclooxygenase enzyme activity, disrupting prostaglandin synthesis and ultimately impeding platelet aggregation. Oral thienopyridines, including clopidogrel, ticagrelor, ticlopidine, and prasugrel, selectively hinder adenosine diphosphate-induced platelet aggregation. Glycoprotein platelet inhibitors act by inhibiting glycoprotein IIb/IIIa receptors on platelets, leading to decreased aggregation, primarily employed in acute coronary syndrome scenarios. Dipyridamole exerts its effects by inhibiting platelet cyclic nucleotide phosphodiesterase, preventing platelet aggregation, and promoting vasodilation. On the other hand, Cilostazol exhibits vasodilatory, antiplatelet, and antiproliferative attributes, mitigating smooth muscle cell overgrowth and intimal thickening following endothelial injury. The mode of administration varies, encompassing oral, rectal, or intravenous routes, contingent upon the particular medication in question.
FutureWise Market Research has published a report that provides an insightful analysis of Antiplatelet Drugs Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Antiplatelet Drugs Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.